Home » Topics » Regulatory

Regulatory
RSS

First regulatory approval for impotence treatment

Nov. 21, 1996

Otsuka discloses inhibitor of TNF-alpha production

Nov. 21, 1996

FDA approves treatment for homocystinuria

Nov. 19, 1996

FDA approves once-daily antihypertensive combination

Nov. 15, 1996

More convenient formulation of Azmacort cleared for asthma prophylaxis

Nov. 15, 1996

New MS treatment approved in Israel

Nov. 15, 1996

New formulation of Leukine approved by FDA

Nov. 15, 1996

New formulation of amifostine covered by U.S. patent

Nov. 15, 1996

First chemotherapeutic drug approved for advanced hormone-refractory prostate cancer

Nov. 15, 1996

Collaborative combination drug trial to begin in HIV-infected patients

Nov. 15, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 11, 2026.
First measles treatment advances as vaccination rates drop
BioWorld
Scientists at the La Jolla Institute for Immunology have identified and characterized human antibodies that neutralize the measles virus by blocking its entry...
Infensa Bioscience identifies new ASIC blockers
BioWorld Science
Infensa Bioscience Pty Ltd. has patented new acid-sensing ion channel 1 (ASIC) blockers potentially useful for the treatment of stroke, among others.
Hantavirus is ‘sentinel’ more than acute pandemic threat
BioWorld
News of eight infections and three deaths so far due to an emerging zoonotic virus has brought back unhappy memories of the early days of SARS-CoV-2. At a press...
Italy’s Angelini pays $4.1B cash for rare disease specialist Catalyst
BioWorld
Italian family-owned Angelini Pharma SpA is making its first move into the U.S. market, acquiring rare diseases specialist Catalyst Pharma Inc. in an all-cash...